Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS - Summary - MDSpire

Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS

  • By

  • Alain Kabongo Katamba Ilunga

  • Chloé Kayembe Musuamba

  • Cagod Inkale

  • Tarcise Kilara

  • Isaac Woto

  • Berry Ikolango Bongenya

  • Gisele Kasanka Kabengele

  • Baudouin Buassa

  • Dieudonné Tshipukane Nyembue

  • Benoit Obel Kabengele

  • Erick Ntambwe Kamangu

  • January 22, 2026

  • 0 min

Share

Objective:

To investigate HTLV-1 and HCV infections in polytransfused sickle cell patients in Kinshasa using molecular biology techniques, highlighting the implications for transfusion safety.

Key Findings:
  • 11.1% of polytransfused sickle cell patients tested positive for HCV infection, indicating a significant risk.
  • The majority of patients were aged 16 to 25 years (46.7%) and predominantly female (51.1%), suggesting demographic trends.
  • The median number of transfusions among participants was 24, highlighting the extent of transfusion exposure.
Interpretation:

The study highlights a significant prevalence of HCV infection among polytransfused sickle cell patients, emphasizing the urgent need for molecular testing to improve transfusion safety.

Limitations:
  • The study was limited to a single center in Kinshasa, which may not represent the broader population, potentially affecting the generalizability of the findings.
  • The sample size of 90 may not be sufficient to generalize findings, indicating a need for larger studies.
Conclusion:

Molecular testing for HCV and HTLV-1 is crucial for improving transfusion safety in sickle cell disease patients in DRC, and should inform public health policies.

Original Source(s)

Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS

  • by Alain Kabongo Katamba Ilunga, Chloé Kayembe Musuamba, Cagod Inkale, Tarcise Kilara, Isaac Woto, Berry Ikolango Bongenya, Gisele Kasanka Kabengele, Baudouin Buassa, Dieudonné Tshipukane Nyembue, Benoit Obel Kabengele, Erick Ntambwe Kamangu

  • January 22, 2026

Related Content

Tocilizumab as a novel bridging therapy for surgery in dedifferentiated liposarcoma complicated by paraneoplastic leukemoid reaction, severe anemia, and thrombocytopenia: a case report

Smoldering Waldenström macroglobulinemia coexisting with myelodysplastic syndrome: a rare case report and literature review

Surgical Intervention for Emphysematous Osteomyelitis of the Spine in a Patient with Malnutrition and Anemia: A Unique Case Study